Emfo, LLC Cybin Inc. Call Options Transaction History
Emfo, LLC
- $110 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYBN
# of Institutions
7Shares Held
54.4KCall Options Held
0Put Options Held
0-
Unique Wealth Strategies, LLC Burr Ridge, IL12.7KShares$118,3970.0% of portfolio
-
Covington Capital Management10KShares$93,3000.0% of portfolio
-
Kistler Tiffany Companies, LLC Berwyn, PA3.6KShares$33,5880.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.5KShares$23,3250.0% of portfolio
-
Column Capital Advisors, LLC900Shares$8,3970.0% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1.55B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...